#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	614	CRP	633	633	99.37	CRP.l15.c30.ctg.1	1144	28.6	0	.	p	.	0	K29T	NONSYN	85	87	AAG	295	297	ACG	40;40;39	A;C;G	40;40;39	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	614	CRP	633	633	99.37	CRP.l15.c30.ctg.1	1144	28.6	0	.	p	.	0	T209S	NONSYN	625	627	ACT	835	837	TCT	25;25;23	T;C;T	25;25;23	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2402	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1439	81.2	1	SNP	p	R234F	1	.	.	700	702	TTC	928	930	TTC	130;127;132	T;T;C	129;126;132	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2402	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1439	81.2	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1228	1230	CGT	112;112;112	C;G;T	112;112;111	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2402	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1439	81.2	0	HET	.	.	.	C261T	.	261	261	C	489	489	C	94	C,T	64,29	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2402	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1439	81.2	0	HET	.	.	.	T999C	.	999	999	T	1227	1227	T	108	T,C	66,41	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2402	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1439	81.2	0	HET	.	.	.	T180C	.	180	180	T	408	408	T	59	T,C	35,18	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2402	Escherichia_coli_EF_Tu	1230	65	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.2	247	10.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	612	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1433	21.6	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1386	1388	AAA	8;7;7	A;A;A	8;7;7	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1086	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l6.c30.ctg.1	1746	33.4	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1287	1289	GAA	40;40;39	G;A;A	40;40;39	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	236	H_NS	414	414	99.03	H_NS.l6.c17.ctg.1	779	16.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	516	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1529	18.0	0	.	p	.	0	A125E	NONSYN	373	375	GCA	530	532	GAA	18;17;17	G;A;A	18;17;17	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	516	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1529	18.0	0	.	p	.	0	M185T	NONSYN	553	555	ATG	710	712	ACC	14;13;14	A;C;C	14;13;14	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	516	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1529	18.0	0	.	p	.	0	S225T	NONSYN	673	675	TCC	830	832	ACT	9;10;10	A;C;T	9;10;10	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	516	PmrE	1167	1167	96.92	PmrE.l6.c30.ctg.1	1529	18.0	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1220	1222	ATC	14;15;15	A;T;C	14;15;15	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	696	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1424	26.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	56	TEM_1+	858	377	98.94	TEM_1+.l6.c30.ctg.1	390	3.3	0	.	p	.	0	F19L	NONSYN	55	57	TTT	68	70	CTT	6;6;6	C;T;T	6;6;6	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	56	TEM_1+	858	377	98.94	TEM_1+.l6.c30.ctg.1	390	3.3	0	.	p	.	0	V82I	NONSYN	244	246	GTT	257	259	ATT	3;3;4	A;T;T	3;3;4	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	56	TEM_1+	858	159	100.0	TEM_1+.l6.c30.ctg.2	159	3.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2042	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3512	31.1	0	.	p	.	0	T85I	NONSYN	253	255	ACC	483	485	ATC	24;24;23	A;T;C	24;24;22	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2042	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3512	31.1	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2196	2198	AAG	24;24;24	A;A;G	23;23;24	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	908	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1598	30.5	0	.	p	.	0	A22V	NONSYN	64	66	GCC	278	280	GTC	15;16;16	G;T;C	15;16;16	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	908	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1598	30.5	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1019	1021	TGC	43;44;43	T;G;C	43;43;43	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2388	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3528	36.0	0	.	p	.	0	S46trunc	TRUNC	136	136	T	338	338	T	22	T	22	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2388	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3528	36.0	0	.	p	.	0	G148D	NONSYN	442	444	GGC	644	646	GAC	55;56;57	G;A;C	55;55;57	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2388	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3528	36.0	0	.	p	.	0	F240L	NONSYN	718	720	TTT	920	922	TTA	16;15;16	T;T;A	16;15;16	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2388	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3528	36.0	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1997	1999	AAT	62;62;60	A;A;T	62;62;60	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2388	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3528	36.0	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2111	2113	AGT	30;31;31	A;G;T	30;31;31	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2388	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3528	36.0	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2510	2512	GTG	36;36;35	G;T;G	36;36;35	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	2388	acrF	3105	3105	98.78	acrF.l15.c4.ctg.1	3528	36.0	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3065	3067	AAG	20;21;19	A;A;G	20;21;19	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	574	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1055	29.1	1	SNP	p	R45C	0	.	.	133	135	CGC	341	343	CGC	39;43;42	C;G;C	39;43;42	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	512	acrS	663	663	98.79	acrS.l15.c4.ctg.1	1014	27.0	0	.	p	.	0	L34F	NONSYN	100	102	CTC	153	155	TTC	27;27;27	T;T;C	27;27;27	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	512	acrS	663	663	98.79	acrS.l15.c4.ctg.1	1014	27.0	0	.	p	.	0	E122G	NONSYN	364	366	GAG	417	419	GGG	45;43;42	G;G;G	45;43;42	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2366	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3145	40.4	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2140	2142	GCA	50;50;52	G;C;A	50;49;52	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2366	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3145	40.4	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2401	2403	ACC	53;54;54	A;C;C	53;54;54	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2366	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3145	40.4	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2710	2712	GCC	50;51;48	G;C;C,T	50;51;47,1	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1044	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2222	24.9	0	.	p	.	0	G37A	NONSYN	109	111	GGT	196	198	GCT	5;5;6	G;C;T	5;5;6	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1044	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2222	24.9	0	.	p	.	0	D77E	NONSYN	229	231	GAT	316	318	GAG	5;4;4	G;A;G	5;4;4	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1044	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2222	24.9	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	352	354	TGC	7;7;9	T;G;C	7;7;9	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1044	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2222	24.9	0	.	p	.	0	I150V	NONSYN	448	450	ATT	535	537	GTT	18;19;20	G;T;T	18;19;20	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1044	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2222	24.9	0	.	p	.	0	R200H	NONSYN	598	600	CGC	685	687	CAC	27;26;26	C;A;C	27;26;26	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1044	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2222	24.9	0	.	p	.	0	T295M	NONSYN	883	885	ACG	970	972	ATG	38;38;38	A;T;G	38;38;38	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1044	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2222	24.9	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1966	1968	CGC	22;23;25	C;G;C	22;23;24	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	420	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1076	19.9	0	.	p	.	0	S221T	NONSYN	661	663	AGC	898	900	ACC	12;11;10	A;C;C	12;11;10	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	420	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1076	19.9	0	.	p	.	0	P225S	NONSYN	673	675	CCG	910	912	TCG	11;11;12	T;C;G	11;11;12	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	1	380	baeR	723	517	97.68	baeR.l15.c17.ctg.1	763	22.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	1	380	baeR	723	185	98.38	baeR.l15.c17.ctg.2	216	11.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	734	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1541	24.6	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1253	1255	AAA	13;13;12	A;A;A	13;13;12	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	734	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1541	24.6	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1265	1267	GAG	7;6;7	G;A;G	7;5;7	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	734	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1541	24.6	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1271	1273	CAC	6;8;9	C;A;C	6;8;9	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	734	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1541	24.6	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1325	1327	GAG	14;12;10	G;A;G	14;12;10	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1086	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1855	31.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	684	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1182	31.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	606	cysB	975	975	99.38	cysB.l15.c4.ctg.1	1351	24.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	782	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1331	30.0	0	.	p	.	0	W42C	NONSYN	124	126	TGG	259	261	TGT	19;18;18	T;G;T,G	19;18;17,1	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	782	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1331	30.0	0	.	p	.	0	I219V	NONSYN	655	657	ATC	790	792	GTC	47;48;48	G;T;C	47;46;48	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	1134	emrB	1539	1539	99.81	emrB.l15.c4.ctg.1	2021	30.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	852	emrD	1191	1191	98.57	emrD.l15.c4.ctg.1	1642	27.7	0	.	p	.	0	G209S	NONSYN	625	627	GGC	862	864	AGC	25;26;25	A;G;C	25;26;25	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	36	emrE_1	333	95	96.84	emrE_1.l15.c4.ctg.1	119	7.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	678	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1280	26.4	0	.	p	.	0	K176R	NONSYN	526	528	AAG	729	731	AGG	19;20;23	A;G;G	19;20;23	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	678	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1280	26.4	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1119	1121	GAC	18;18;18	G;A;C	18;18;18	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	448	emrR	531	531	100.0	emrR.l6.c4.ctg.1	1060	22.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1066	emrY	1539	1539	99.81	emrY.l15.c17.ctg.1	2021	28.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	446	evgA	615	615	99.19	evgA.l15.c17.ctg.1	860	26.6	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	258	260	CTG	31;31;31	C;T;G,A	31;31;30,1	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	T38I	NONSYN	112	114	ACA	337	339	ATA	11;11;11	A;T;A	10;11;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	L42V	NONSYN	124	126	CTA	349	351	GTA	8;9;9	G;T;A	8;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	A93T	NONSYN	277	279	GCG	502	504	ACG	14;13;12	A;C;G	14;13;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	A114E	NONSYN	340	342	GCA	565	567	GAA	25;25;25	G;A;A	25;25;25	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	T127A	NONSYN	379	381	ACT	604	606	GCT	26;26;29	G;C;T	26;26;29	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	N133D	NONSYN	397	399	AAT	622	624	GAT	22;22;22	G;A;T,A	22;22;21,1	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	P162S	NONSYN	484	486	CCA	709	711	TCA	24;26;26	T;C;A	24;26;26	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	838	840	CAG	24;23;23	C;A;G	24;23;23	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	I251V	NONSYN	751	753	ATT	976	978	GTT	17;18;18	G;T;T	17;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1132	1134	GAT	6;6;5	G;A;T	6;6;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1300	1302	AAT	9;9;9	A;A;T	9;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1321	1323	TTA	3;3;3	T;T;A	3;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1522	1524	AAA	16;16;16	A;A;A	16;16;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2257	2259	CAT	29;27;29	C;A;T	29;27;29	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2311	2313	CAT	15;15;13	C;A;T	15;15;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2329	2331	AGA	18;19;19	A;G;A	18;19;19	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2344	2346	AAT	17;16;17	A;A;T	17;16;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2491	2493	TCC	13;12;15	T;C;C	13;12;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2656	2658	ATT	18;18;18	A;T;T	18;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2677	2679	GAT	18;18;20	G;A;T	18;18;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2791	2793	GTT	33;32;32	G;T;T	33;31;32	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3076	3078	CAC	33;33;32	C;A;C	33;33;32	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2018	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3990	27.1	0	.	p	.	0	D1197N	NONSYN	3589	3591	GAC	3814	3816	AAC	12;12;12	A;A;C	12;12;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	630	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1269	26.7	1	SNP	p	P64H	0	.	.	190	192	CCA	418	420	CCA	46;47;48	C;C;A	46;46;48	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	630	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1269	26.7	1	SNP	p	P64S	0	.	.	190	192	CCA	418	420	CCA	46;47;48	C;C;A	46;46;48	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	630	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1269	26.7	1	SNP	p	P64L	0	.	.	190	192	CCA	418	420	CCA	46;47;48	C;C;A	46;46;48	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	630	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1269	26.7	1	SNP	p	P64R	0	.	.	190	192	CCA	418	420	CCA	46;47;48	C;C;A	46;46;48	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	630	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1269	26.7	1	SNP	p	P64A	0	.	.	190	192	CCA	418	420	CCA	46;47;48	C;C;A	46;46;48	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	332	gadE	528	528	100.0	gadE.l15.c4.ctg.1	921	19.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	176	gadW	729	126	96.83	gadW.l6.c17.ctg.1	126	32.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	176	gadW	729	299	92.98	gadW.l6.c17.ctg.2	299	8.7	0	.	p	.	0	E54D	NONSYN	160	162	GAA	2	4	GAT	3;4;4	G;A;T	3;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	176	gadW	729	299	92.98	gadW.l6.c17.ctg.2	299	8.7	0	.	p	.	0	I88M	NONSYN	262	264	ATA	104	106	ATG	2;2;2	A;T;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	176	gadW	729	299	92.98	gadW.l6.c17.ctg.2	299	8.7	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	107	109	CCG	2;2;2	C;C;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	176	gadW	729	299	92.98	gadW.l6.c17.ctg.2	299	8.7	0	.	p	.	0	D100E	NONSYN	298	300	GAC	140	142	GAA	2;2;2	G;A;A	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	176	gadW	729	299	92.98	gadW.l6.c17.ctg.2	299	8.7	0	.	p	.	0	P101S	NONSYN	301	303	CCC	143	145	TCC	2;2;2	T;C;C	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	176	gadW	729	299	92.98	gadW.l6.c17.ctg.2	299	8.7	0	.	p	.	0	R102G	NONSYN	304	306	CGG	146	148	GGG	2;2;2	G;G;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	176	gadW	729	299	92.98	gadW.l6.c17.ctg.2	299	8.7	0	.	p	.	0	K110N	NONSYN	328	330	AAA	170	172	AAT	10;10;9	A;A;T	10;10;9	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	490	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1144	23.0	0	.	p	.	0	F53L	NONSYN	157	159	TTC	320	322	TTA	11;11;11	T;T;A	11;11;11	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	490	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1144	23.0	0	.	p	.	0	V79I	NONSYN	235	237	GTT	398	400	ATT	22;22;22	A;T;T	22;22;22	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	490	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1144	23.0	0	.	p	.	0	R246G	NONSYN	736	738	AGA	899	901	GGA	15;15;14	G;G;A	15;15;14	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	490	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1144	23.0	0	.	p	.	0	S248P	NONSYN	742	744	TCG	905	907	CCG	13;14;14	C;C;G	13;14;14	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1982	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3104	34.2	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2253	2255	GAA	34;35;35	G,A;A;A	33,1;35;35	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1982	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3104	34.2	1	SNP	p	S83I	0	.	.	247	249	TCG	468	470	TCG	50;46;46	T;C;G	48;45;46	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1982	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3104	34.2	1	SNP	p	S83L	0	.	.	247	249	TCG	468	470	TCG	50;46;46	T;C;G	48;45;46	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1982	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3104	34.2	1	SNP	p	S83W	0	.	.	247	249	TCG	468	470	TCG	50;46;46	T;C;G	48;45;46	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1982	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3104	34.2	1	SNP	p	D87V	0	.	.	259	261	GAC	480	482	GAC	44;45;44	G;A;C	43;44;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1982	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3104	34.2	1	SNP	p	D87Y	0	.	.	259	261	GAC	480	482	GAC	44;45;44	G;A;C	43;44;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1982	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3104	34.2	1	SNP	p	D87H	0	.	.	259	261	GAC	480	482	GAC	44;45;44	G;A;C	43;44;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1982	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3104	34.2	1	SNP	p	D87G	0	.	.	259	261	GAC	480	482	GAC	44;45;44	G;A;C	43;44;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1982	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3104	34.2	1	SNP	p	D87N	0	.	.	259	261	GAC	480	482	GAC	44;45;44	G;A;C	43;44;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1714	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2923	31.3	1	SNP	p	R136G	0	.	.	406	408	CGC	630	632	CGC	34;33;32	C;G;C	34;33;32	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1714	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2923	31.3	1	SNP	p	R136I	0	.	.	406	408	CGC	630	632	CGC	34;33;32	C;G;C	34;33;32	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1714	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2923	31.3	1	SNP	p	R136S	0	.	.	406	408	CGC	630	632	CGC	34;33;32	C;G;C	34;33;32	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1714	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2923	31.3	1	SNP	p	R136C	0	.	.	406	408	CGC	630	632	CGC	34;33;32	C;G;C	34;33;32	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1714	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2923	31.3	1	SNP	p	R136L	0	.	.	406	408	CGC	630	632	CGC	34;33;32	C;G;C	34;33;32	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1714	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2923	31.3	1	SNP	p	R136H	0	.	.	406	408	CGC	630	632	CGC	34;33;32	C;G;C	34;33;32	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1714	gyrB_1	2415	2415	99.09	gyrB_1.l15.c4.ctg.1	2923	31.3	1	SNP	p	R136E	0	.	.	406	408	CGC	630	632	CGC	34;33;32	C;G;C	34;33;32	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	362	kdpE	678	678	98.23	kdpE.l15.c17.ctg.1	1050	18.5	0	.	p	.	0	A72P	NONSYN	214	216	GCG	416	418	CCG	17;17;17	C;C;G	17;17;17	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	362	kdpE	678	678	98.23	kdpE.l15.c17.ctg.1	1050	18.5	0	.	p	.	0	T123A	NONSYN	367	369	ACC	569	571	GCC	21;20;20	G;C;C	21;20;20	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	812	leuO	945	945	99.15	leuO.l15.c30.ctg.1	1363	31.9	0	.	p	.	0	P9S	NONSYN	25	27	CCA	213	215	TCA	17;17;18	T;C;A	17;17;18	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	812	leuO	945	945	99.15	leuO.l15.c30.ctg.1	1363	31.9	0	.	p	.	0	P121S	NONSYN	361	363	CCG	549	551	TCG	36;35;35	T,C;C;G	35,1;35;34	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	258	marA	384	384	99.74	marA.l15.c4.ctg.1	798	17.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	124	marR	435	394	97.97	marR.l15.c30.ctg.1	643	10.0	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	556	558	AGC	10;11;10	A;G;C	10;11;10	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	124	marR	435	394	97.97	marR.l15.c30.ctg.1	643	10.0	1	SNP	p	V45E	0	.	.	133	135	GTG	382	384	GTG	23;24;24	G;T;G	22;24;24	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	124	marR	435	394	97.97	marR.l15.c30.ctg.1	643	10.0	1	SNP	p	I49S	0	.	.	145	147	ATC	394	396	ATC	17;15;16	A;T;C	17;15;16	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	124	marR	435	394	97.97	marR.l15.c30.ctg.1	643	10.0	1	SNP	p	A70T	0	.	.	208	210	GCA	457	459	GCA	8;8;8	G;C;A	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	124	marR	435	394	97.97	marR.l15.c30.ctg.1	643	10.0	1	SNP	p	R73C	0	.	.	217	219	CGT	466	468	CGT	8;7;7	C;G;T	8;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	124	marR	435	394	97.97	marR.l15.c30.ctg.1	643	10.0	1	SNP	p	R73S	0	.	.	217	219	CGT	466	468	CGT	8;7;7	C;G;T	8;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	124	marR	435	394	97.97	marR.l15.c30.ctg.1	643	10.0	1	SNP	p	R77L	0	.	.	229	231	CGC	478	480	CGC	8;8;8	C;G;C	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	124	marR	435	394	97.97	marR.l15.c30.ctg.1	643	10.0	1	SNP	p	R77C	0	.	.	229	231	CGC	478	480	CGC	8;8;8	C;G;C	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	124	marR	435	394	97.97	marR.l15.c30.ctg.1	643	10.0	1	SNP	p	L78M	0	.	.	232	234	CTG	481	483	CTG	7;7;7	C;T;G	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	124	marR	435	394	97.97	marR.l15.c30.ctg.1	643	10.0	1	SNP	p	R94H	0	.	.	280	282	CGC	529	531	CGC	11;11;11	C;G;C	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	124	marR	435	394	97.97	marR.l15.c30.ctg.1	643	10.0	1	SNP	p	R94S	0	.	.	280	282	CGC	529	531	CGC	11;11;11	C;G;C	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	124	marR	435	394	97.97	marR.l15.c30.ctg.1	643	10.0	1	SNP	p	V96E	0	.	.	286	288	GTA	535	537	GTA	11;11;11	G;T;A	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	462	mdfA	1233	1207	97.02	mdfA.l15.c4.ctg.1	1322	17.9	0	.	p	.	0	R36I	NONSYN	106	108	AGG	80	82	ATC	11;11;11	A;T;C	11;11;11	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	462	mdfA	1233	1207	97.02	mdfA.l15.c4.ctg.1	1322	17.9	0	.	p	.	0	E42A	NONSYN	124	126	GAA	98	100	GCC	4;4;5	G;C;C	4;4;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	462	mdfA	1233	1207	97.02	mdfA.l15.c4.ctg.1	1322	17.9	0	.	p	.	0	N43V	NONSYN	127	129	AAT	101	103	GTG	5;5;5	G;T;G	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	462	mdfA	1233	1207	97.02	mdfA.l15.c4.ctg.1	1322	17.9	0	.	p	.	0	E52D	NONSYN	154	156	GAG	128	130	GAT	6;5;5	G;A;T	6;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	462	mdfA	1233	1207	97.02	mdfA.l15.c4.ctg.1	1322	17.9	0	.	p	.	0	N59T	NONSYN	175	177	AAC	149	151	ACC	4;4;4	A;C;C	4;4;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	462	mdfA	1233	1207	97.02	mdfA.l15.c4.ctg.1	1322	17.9	0	.	p	.	0	I68L	NONSYN	202	204	ATA	176	178	TTA	2;2;3	T;T;A	2;2;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	462	mdfA	1233	1207	97.02	mdfA.l15.c4.ctg.1	1322	17.9	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	317	319	CAG	23;24;22	C;A;G	23;24;22	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	462	mdfA	1233	1207	97.02	mdfA.l15.c4.ctg.1	1322	17.9	0	.	p	.	0	D128A	NONSYN	382	384	GAC	356	358	GCC	13;13;13	G;C;C	13;13;13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	462	mdfA	1233	1207	97.02	mdfA.l15.c4.ctg.1	1322	17.9	0	.	p	.	0	S163A	NONSYN	487	489	TCG	461	463	GCG	14;14;14	G;C;G	14;14;14	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	462	mdfA	1233	1207	97.02	mdfA.l15.c4.ctg.1	1322	17.9	0	.	p	.	0	L231V	NONSYN	691	693	CTT	665	667	GTT	13;13;14	G,T;T;T	9,1;12;13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	462	mdfA	1233	1207	97.02	mdfA.l15.c4.ctg.1	1322	17.9	0	.	p	.	0	R285fs	FSHIFT	853	853	C	827	827	C	14	C	14	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	515	560	mdtA	1248	1154	97.83	mdtA.l6.c30.ctg.1	1342	20.4	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	4	6	CAG	2;4;5	C;A;G	1;3;4	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	515	560	mdtA	1248	1154	97.83	mdtA.l6.c30.ctg.1	1342	20.4	0	.	p	.	0	T83I	NONSYN	247	249	ACC	154	156	ATC	8;8;6	A;T;C	8;7;6	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	515	560	mdtA	1248	1154	97.83	mdtA.l6.c30.ctg.1	1342	20.4	0	.	p	.	0	I99M	NONSYN	295	297	ATA	202	204	ATG	8;9;9	A;T;G	8;9;8	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	515	560	mdtA	1248	1154	97.83	mdtA.l6.c30.ctg.1	1342	20.4	0	.	p	.	0	A130T	NONSYN	388	390	GCC	295	297	ACC	10;10;10	A;C;C	10;10;10	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	515	560	mdtA	1248	121	93.39	mdtA.l6.c30.ctg.2	144	10.5	0	.	p	.	0	V12trunc	TRUNC	34	34	G	63	63	G	20	G	20	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	515	560	mdtA	1248	121	93.39	mdtA.l6.c30.ctg.2	144	10.5	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	120	122	CAG	4;2;2	C;A;G	4;2;2	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1974	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3335	31.5	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1854	1856	ACC	41;43;43	A;C;C	40;43;43	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1974	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3335	31.5	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2247	2249	CAA	23;22;22	C;A;A	21;22;22	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1974	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3335	31.5	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2415	2417	ATT	19;19;19	A;T;T	19;19;19	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1974	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3335	31.5	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2499	2501	GTT	23;23;23	G;T;T	23;23;23	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1974	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3335	31.5	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2607	2609	GAG	29;29;27	G;A;G	29;29;27	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1974	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3335	31.5	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2835	2837	ATG	23;23;23	A;T;G	23;23;23	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1974	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3335	31.5	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	2970	2972	GAT	25;25;25	G;A;T	25;24;25	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1752	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3472	27.1	0	.	p	.	0	I46M	NONSYN	136	138	ATC	331	333	ATG	10;10;10	A;T;G	10;10;10	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1752	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3472	27.1	0	.	p	.	0	V208I	NONSYN	622	624	GTC	817	819	ATC	41;41;43	A;T;C	41;41;43	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1752	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3472	27.1	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3133	3135	CAC	3;3;3	C;A;C	3;3;3	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	764	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1842	22.1	0	.	p	.	0	D3E	NONSYN	7	9	GAT	136	138	GAA	17;16;16	G;A;A	17;16;16	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	764	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1842	22.1	0	.	p	.	0	T226A	NONSYN	676	678	ACG	805	807	GCG	25;25;24	G;C;G	25;25;24	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	764	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1842	22.1	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1147	1149	ATC	24;25;25	A;T;C	23;25;25	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	764	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	1842	22.1	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1450	1452	TTT	26;29;30	T;T;T	26;29;30	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	976	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1577	33.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2372	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3582	35.5	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1109	1111	ACC	17;18;17	A;C;C	17;17;17	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2372	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3582	35.5	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2351	2353	GAC	36;36;36	G;A;C	36;35;36	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	840	mdtG	1227	1047	99.43	mdtG.l15.c30.ctg.1	1478	25.3	0	.	p	.	0	V200I	NONSYN	598	600	GTC	626	628	ATC	24;26;26	A;T;C	23;25;25	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	840	mdtG	1227	145	99.31	mdtG.l15.c30.ctg.2	324	12.7	0	.	p	.	0	E5G	NONSYN	13	15	GAA	192	194	GGA	7;7;7	G;G;A	7;7;7	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	648	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1367	24.6	0	.	p	.	0	G134C	NONSYN	400	402	GGT	404	406	TGT	32;32;33	T;G;T	32;32;33	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	648	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1367	24.6	0	.	p	.	0	S324L	NONSYN	970	972	TCG	974	976	TTG	28;29;29	T;T;G	28;29;29	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	648	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1367	24.6	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1184	1186	ACG	10;10;10	A;C;G	10;10;10	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	826	mdtL	1176	1176	98.21	mdtL.l15.c30.ctg.1	1646	27.0	0	.	p	.	0	A185S	NONSYN	553	555	GCC	758	760	TCC	30;30;30	T;C;C	29;30;30	.	Multidrug resistance protein MdtL;mdtL
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2102	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3869	29.1	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1514	1516	AAG	26;26;27	A;A;G	26;25;26	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2102	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3869	29.1	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2591	2593	CTG	27;28;28	C;T;G	27;27;28	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	172	mgrB	144	144	100.0	mgrB.l15.c30.ctg.2	165	28.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1346	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2093	34.5	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1006	1008	AAC	20;19;19	A;A;C	20;19;19	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1346	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2093	34.5	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1552	1554	ATA	26;27;27	A;T;A	26;27;27	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	936	murA_12	1260	1260	98.57	murA_12.l15.c30.ctg.1	1695	29.5	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1318	1320	GAT	40;41;44	G;A;T	40;41;43	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	936	murA_12	1260	1260	98.57	murA_12.l15.c30.ctg.1	1695	29.5	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1321	1323	CTG	43;44;43	C;T;G	43;44;42	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	334	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1132	15.9	0	.	p	.	0	R27C	NONSYN	79	81	CGT	266	268	TGT	15;14;14	T;G;T	15;14;14	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	334	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1132	15.9	0	.	p	.	0	I117T	NONSYN	349	351	ATC	536	538	ACC	27;27;25	A;C;C	27;27;25	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	334	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1132	15.9	0	.	p	.	0	G187D	NONSYN	559	561	GGC	746	748	GAC	15;15;15	G;A;C	15;14;15	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	334	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1132	15.9	1	SNP	p	R15C	0	.	.	43	45	CGC	230	232	CGC	21;21;20	C;G;C	21;21;20	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	334	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1132	15.9	1	SNP	p	S33R	0	.	.	97	99	AGC	284	286	AGC	15;15;16	A;G;C	14;15;16	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	334	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1132	15.9	1	SNP	p	G131D	0	.	.	391	393	GGC	578	580	GGC	23;24;25	G;G;C	23;23;24	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	334	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1132	15.9	1	SNP	p	R203C	0	.	.	607	609	CGT	794	796	CGT	17;17;18	C;G;T	17;16;18	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	334	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1132	15.9	1	SNP	p	R203L	0	.	.	607	609	CGT	794	796	CGT	17;17;18	C;G;T	17;16;18	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	966	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1515	34.1	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1158	1160	GAG	43;47;47	G;A;G	43;47;47	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	966	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1515	34.1	1	SNP	p	G141E	0	.	.	421	423	GGT	645	647	GGT	32;31;32	G;G;T	32;31;32	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	966	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1515	34.1	1	SNP	p	G141D	0	.	.	421	423	GGT	645	647	GGT	32;31;32	G;G;T	32;31;32	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	966	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1515	34.1	1	SNP	p	R154A	0	.	.	460	462	CGT	684	686	CGT	49;50;51	C;G;T	48;50;50	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	966	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1515	34.1	1	SNP	p	R154D	0	.	.	460	462	CGT	684	686	CGT	49;50;51	C;G;T	48;50;50	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1992	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2687	39.6	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1892	1894	TCG	49;50;52	T;C;G	49;49;52	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1992	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2687	39.6	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2507	2509	AAC	28;26;26	A;A;C	28;26;26	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1992	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2687	39.6	1	SNP	p	A85T	0	.	.	253	255	GCG	521	523	GCG	53;52;52	G;C;G	50;48;49	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1992	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2687	39.6	1	SNP	p	D111H	0	.	.	331	333	GAT	599	601	GAT	26;26;27	G;A;T	26;25;27	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1992	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2687	39.6	1	SNP	p	S129P	0	.	.	385	387	TCC	653	655	TCC	39;39;40	T;C;C	37;39;40	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1178	parE_1	1893	1893	97.46	parE_1.l15.c30.ctg.1	2221	27.8	0	.	p	.	0	H51P	NONSYN	151	153	CAC	200	202	CCC	8;8;11	C;C,A;C	3;0,4;9	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1178	parE_1	1893	1893	97.46	parE_1.l15.c30.ctg.1	2221	27.8	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1475	1477	GAT	49;50;50	G;A;T	49;50;50	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1126	patA	1380	1380	99.86	patA.l15.c30.ctg.1	1880	32.2	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1311	1313	GAT	40;40;38	G;A;T	40;40;38	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3656	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4444	44.1	1	SNP	p	V146F	0	.	.	436	438	GTT	625	627	GTT	46;45;41	G;T;T	45;45;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3656	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4444	44.1	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1726	1728	CAG	46;43;43	C;A;G	46;43;43	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3656	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4444	44.1	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1726	1728	CAG	46;43;43	C;A;G	46;43;43	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3656	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4444	44.1	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1765	1767	CAC	40;40;40	C;A;C	40;39;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3656	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4444	44.1	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1774	1776	CGT	38;39;41	C;G;T	38;39;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3656	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4444	44.1	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1774	1776	CGT	38;39;41	C;G;T	38;39;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3656	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4444	44.1	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1780	1782	TCC	38;37;37	T;C;C	38;37;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3656	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4444	44.1	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1786	1788	CTC	36;36;34	C;T;C	36;36;34	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3656	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4444	44.1	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1876	1878	ACC	58;61;61	A;C;C	58;61;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3656	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4444	44.1	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1879	1881	CCT	58;55;55	C;C;T	58;55;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3656	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4444	44.1	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2248	2250	CGT	74;74;74	C;G;T	73;73;73	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	0	.	n	.	0	A226G	SNP	226	226	A	351	351	G	332	G	330	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	1	SNP	n	A794G	0	.	.	794	794	A	919	919	A	242	A	238	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	1	SNP	n	A794T	0	.	.	794	794	A	919	919	A	242	A	238	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	1	SNP	n	G926A	0	.	.	926	926	G	1051	1051	G	261	G	261	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	1	SNP	n	G926T	0	.	.	926	926	G	1051	1051	G	261	G	261	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	1	SNP	n	G926C	0	.	.	926	926	G	1051	1051	G	261	G	261	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	1	SNP	n	A1519T	0	.	.	1519	1519	A	1644	1644	A	176	A	175	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	1	SNP	n	A1519G	0	.	.	1519	1519	A	1644	1644	A	176	A	175	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	1	SNP	n	A1519C	0	.	.	1519	1519	A	1644	1644	A	176	A	175	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	0	HET	.	.	.	G1002A	.	1002	1002	G	1127	1127	G	292	G,A	179,112	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	0	HET	.	.	.	G1006C	.	1006	1006	G	1131	1131	G	279	G,C	172,105	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	0	HET	.	.	.	A79G	.	79	79	A	204	204	A	246	A,G	186,58	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	0	HET	.	.	.	C719T	.	719	719	C	844	844	C	246	C,T	169,76	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	0	HET	.	.	.	T273A,C	.	273	273	T	398	398	T	270	T,A,C	205,60,2	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	0	HET	.	.	.	T1010C	.	1010	1010	T	1135	1135	T	281	T,C	172,104	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	0	HET	.	.	.	C1038T	.	1038	1038	C	1163	1163	C	256	C,T	150,102	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	0	HET	.	.	.	C183T	.	183	183	C	308	308	C	281	C,T	193,87	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	0	HET	.	.	.	A250T	.	250	250	A	375	375	A	290	A,T	218,69	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	0	HET	.	.	.	T90C	.	90	90	T	215	215	T	242	T,C	195,46	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	0	HET	.	.	.	G474A	.	474	474	G	599	599	G	253	G,A	185,66	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	0	HET	.	.	.	A253T	.	253	253	A	378	378	A	291	A,T	222,69	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	9064	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.2	1679	269.2	0	HET	.	.	.	C194T	.	194	194	C	319	319	C	302	C,T	241,60	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	448	soxR	465	465	100.0	soxR.l15.c4.ctg.1	869	27.6	1	SNP	p	R20H	0	.	.	58	60	CGC	247	249	CGC	38;40;40	C;G;C	38;40;40	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	448	soxR	465	465	100.0	soxR.l15.c4.ctg.1	869	27.6	1	SNP	p	G121D	0	.	.	361	363	GGT	550	552	GGT	43;40;39	G;G;T	43;40;39	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	324	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	712	24.3	1	SNP	p	A12S	0	.	.	34	36	GCA	228	230	GCA	39;39;39	G;C;A	39;39;39	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	27	6810	sul2	816	816	100.0	sul2.l15.c4.ctg.1	1346	270.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1206	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	2021	32.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
